Rethinking ADHD Podcast

Dr. James Wiley, Dr. David Aversa, and Qbtech's medical expert, Ragini Sanyal, discuss patient and clinician experiences of objective testing. Dr. Wiley shares the story of a patient experiencing worsening mood and anxiety problems, despite being on several psychotropic medications and ADHD stimulants. Insights from objective testing helped clinicians to adjust stimulant type and dose, allowing the patient to come off psychotropic medications and improve school performance. The panel also discusses how objective measures can support dose optimization, helping clinicians balance effectiveness without overmedication. Ragini Sanyal also shares insights from research on using QbCheck to monitor treatment response.Interested in such insights? Check out our Rethinking ADHD podcast hub for the latest episodes, practical insights, and honest conversations, by clinicians for clinicians: https://bit.ly/4vrK0J5

In this episode of Rethinking ADHD, leading ADHD experts discuss common challenges with titrating ADHD medication. They also discuss the role of objective ADHD measures in dose optimization and improving treatment confidence for clinicians, parents, and patients.Watch the full podcast: https://bit.ly/3RBdw0yTopics covered:– Why ADHD medication titration is highly individualized– The importance of finding the right dose for the right patient– Challenges with parent and teacher feedback during treatment– How objective measures can support clinical decision-making– Common concerns parents have about stimulant medication– Why “start low and go slow” matters in ADHD care– The role of metabolism, symptom response, and functional improvement in medication effectivenessWho this is for:Clinicians, pediatricians, psychiatrists, mental health professionals.

In this episode of Rethinking ADHD, ADHD experts explore the role of objective measures in supporting medication titration and treatment monitoring. The discussion covers why ADHD medication response varies between patients, the challenges of relying solely on subjective feedback, and how objective data can help clinicians evaluate symptom change and functional improvement over time.The episode also examines common parent concerns around ADHD medication, the importance of individualized treatment approaches, and why effective titration is about more than simply increasing dosage.A practical conversation for clinicians, psychiatrists, pediatricians, and mental health professionals interested in evidence-based ADHD care and improving treatment outcomes.Watch the podcast instead: https://bit.ly/4nG9pfq

Trauma, autism, anxiety, or sleep problems; many patients present with overlapping conditions that muddy the diagnostic waters. In this episode, our ADHD experts unpack how clinicians can use a comorbidity-informed lens to interpret assessments, including objective tools such as QbCheck.Plus, they explore triage strategies that protect patient safety without overloading the system. To watch the podcast instead, check out our YouTube channel: https://bit.ly/4uycroD

In this episode, our clinical expert Jess Brunet is in conversation with Ceri Reed, Founder of Parents Voices in Wales CIC, and Penny Lazell, Senior Clinical Advisor at Qbtech. They explore what “holistic ADHD care” really means and why a comprehensive approach can transform outcomes for patients.Whether you’re a mental‑health professional, clinician, ADHD advocate, or someone interested in improving ADHD care, this episode is for you.To watch the podcast: https://bit.ly/4bZCHQY

In this episode of Rethinking ADHD, Dr James Wiley MD and Dr David Aversa, MD, MPH joined Qbtech’s Head of Clinical Research, Ragini Sanyal, to unpack what modern medication management looks like and how tools like QbCheck are helping clinicians titrate with greater clarity and confidence. Speaker info: Dr James Wiley, MD, FocusMD Dr David Aversa, MD, MPH, CT Psych and Wellness/BeaconRagini Sanyal, Head of Clinical Research, QbtechWant to understand the correlation between titration and objective data? Want episodes like this in your inbox? Join the Rethinking ADHD community 

ADHD goes beyond inattention and hyperactivity. It affects emotions, relationships, careers, and daily life in ways that many, even those living with ADHD, may not fully understand. This episode of our ADHD podcast series covers the realities of experiencing neurodivergence, including delayed diagnoses, difficulties with emotional dysregulation, coping strategies and the importance of a clinician’s role in a patient's ADHD care journey.  The conversation between Duane Gordon, President of ADDA, Helen Turnbull, Evelyn Polk-Green, Ex President of ADDA, and Katie Hathaway, M.S, BCBA, is one of honesty, humor, and insight, offering a deeper understanding of ADHD that textbooks often miss.

ADHD is a neurodevelopmental disorder, meaning symptoms must have been present since childhood (APA, DSM-5). Understanding a patient’s early development is critical when assessing and treating ADHD. A thorough developmental history helps clinicians differentiate symptoms from comorbid conditions like autism, learning disorders, or anxiety.The latest webinar, led by our clinical experts Jess Brunett, Ryan Martin, and Penny Lazell, delves into the critical role data gathering and developmental history play in an ADHD diagnosis.